Subscribe

Spotlight -

Thomas Grader-Beck, MD

Thomas Grader-Beck, MD

Associate Professor of Clinical Medicine at Johns Hopkins University of Medicine

Articles by Thomas Grader-Beck, MD

Breakthrough Therapy Ianalumab Efficacious, Safe for Sjögren, With Thomas Grader-Beck, MD

Breakthrough Therapy Ianalumab Efficacious, Safe for Sjögren, With Thomas Grader-Beck, MD

ByThomas Grader-Beck, MD

February 4th 2026

Grader-Beck emphasized the potential of ianalumab for improving treatment options for Sjögren disease.

Breakthrough Therapy Ianalumab Nears FDA Submission for Sjögren, With Thomas Grader-Beck, MD

Breakthrough Therapy Ianalumab Nears FDA Submission for Sjögren, With Thomas Grader-Beck, MD

ByThomas Grader-Beck, MD

January 28th 2026

Latest Updated Articles

Trending on Rheumatology Live

Belimumab Nearly Doubled Non-GC Remission and LLDAS Rates in SLE Post-Hocs

Risankizumab’s Durable Efficacy, Safety in PsA, With Frank Behrens, MD

Allocetra Immunotherapy Gets RMAT Designation for Age-Related Knee Osteoarthritis

Joint Ventures Recaps Influential EULAR Studies in SLE, RA, and More